Tagged with ARM

Farmacias del Ahorro First of all, congratulations on the new distribution warehouse in Lerma, State of Mexico . You mentioned that there were two more to come: can you give us a bit more information about timings and differentiation strategies moving forward in terms of distribution to increase your share of the pharmacy…

Asociace inovativního farmaceutického průmyslu (AIFP) Mr. Dvořáček, in 2010, the AIFP commissioned a study on the economic footprint of the innovative pharmaceutical industry in the Czech Republic. Can you begin by expounding the results of this study? The footprint of the innovative pharma industry in this market is not particularly large relative to other industries,…

Hayat Pharmaceutical Industries (HPI) The company was one of the last Jordanian pharma companies to be founded and started production only in 1997… How was Hayat able to establish itself among the leading pharma companies in the country so quickly? What is the key ingredient for the company’s success? We started commercial production and…

Pharma International Co. (PIC) You took over from your father in 2006. What have been the key milestones & achievements in the company’s development since then and how does your approach differentiate from your father’s? I joined Pharma International in 2006. We had already started our production in 2000. Previously we had a British…

Pierre Fabre Farma de México Please can you give us a brief rundown of Pierre Fabre’s activities in Mexico since they opened an affiliate here, specifically the company’s milestones and achievements along the way? Pierre Fabre (PF) is now celebrating its 51st anniversary as 2012 rolls in. A French based company founded by Mr. Pierre…

The Government Pharmaceutical Organization (G Dr. Witit, when we interviewed your predecessor in 2006, we talked about the vital role and leading position GPO plays in the Thai pharmaceutical industry and the company’s investments in manufacturing facilities to improve access and affordability of drugs. What have been some of the most important milestones since you…

Zuellig Pharma Thailand ‘When markets are inefficient, relationships are important. When markets are more efficient, relationships become less important because the markets become more systematic, professional, and objective in the way they operate,’ said Mr. Zwisler, former CEO of Zuellig Pharma Asia Pacific when we interviewed him in China. At which development stage…

Biofarma Turkey Mr Sözeri, Pharmaceutical Executive’s readers are keen to discover, through our reports, prominent industry personalities, and they like to hear their stories. You have an outstanding career, having worked for both international and local giants – Deva, Abdi Ibrahim, Actavis, Astra Zeneca…- Can you tell us a little bit more…

More Pharma Mexico There are about 250 employees and you have regional presence in Latin America. In your view as CEO, can you tell our readers about the biggest growth drivers and challenges in the Mexican pharmaceutical market since then? At More Pharma we believe we are navigating at an ever changing environment.…

Shire Pharmaceuticals Please can you give us a rundown of Shires activities in Mexico in the last four years, and the key achievements and milestones along the way? Shire started operations in Mexico in 2008, a similar story to Brazil. There are very few people working here in Shire Mexico but we…

Octapharma Mexico Please can you give our readers a brief rundown of the major milestones and challenges that you have faced at Octapharma since becoming Managing Director? When Octapharma first came to Mexico in 1994, it was through a distribution agreement with a local company. Six years later in the year 2000…

Hutchison Medipharma You began your career at Pfizer, working your way up the organizational ladder, when suddenly you decided to come to China back in 2001, well before China was on the map for R&D. What drove you to make this choice, to take the risk and come to China? It wasn’t…